Hypopharynx Cancer Clinical Trials

22 clinical trials for Hypopharynx Cancer across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population — RECRUITING · PHASE2
• Lymphocyte-Sparing And Radio-Immunotherapy in Head and Neck Carcinoma — RECRUITING · PHASE3
• A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC) — RECRUITING · PHASE2
• Special Care Patterns for Elderly HNSCC Patients Undergoing Radiotherapy — RECRUITING
• SBRT Followed by Chemoimmunotherapy of Toripalimab Plus Docetaxel and Cisplatin for Larynx Preservation in Patients with Locally Regionally Advanced Squamous Cell Carcinoma of the Larynx and Hypopharynx — RECRUITING · PHASE2
• Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma — COMPLETED · PHASE2
• The ENHANCE Study: Exercise and Nutrition in Head And Neck CancEr Survivors — ACTIVE_NOT_RECRUITING · NA
• Pembrolizumab in Combination With CRT for LA-SCCHN — COMPLETED · PHASE1
• Tislelizumab and Induction Chemotherapy for Larynx Preservation in Resectable Advanced Laryngeal/Hypopharyngeal Cancer — NOT_YET_RECRUITING · PHASE2
• A Study of Concurrent Chemoradiation in Combination With or Without PD1 Inhibitor AB122 Adenosine 2a Receptor / Adenosine 2b Receptor Inhibitor AB928 Therapies in Locally Advanced Head and Neck Cancers — WITHDRAWN · PHASE1
• Immunological Function After Radiation With Either Proton or Photon Therapy — OTHER
• Induction Chemotherapy and Toripalimab for Larynx Preservation in Resectable Laryngeal/Hypopharyngeal Carcinoma — OTHER · PHASE2
• Adaptive Radiotherapy for Head and Neck Cancer — COMPLETED · PHASE2
• Cell-free Tumor DNA in Head and Neck Cancer Patients — OTHER · NA
• IMRT Plus Cisplatin Versus Conventional Radiotherapy Plus Cisplatin in Stage III-IV HNSCC — COMPLETED · PHASE3
• Induction CT by Cisplatin, 5FU With or Without Docetaxel in Patients With T3 and T4 Larynx and Hypopharynx Carcinoma — COMPLETED · PHASE3
• A Novel Modified Tracheo-Esophageal Voice Prosthesis for Total Laryngectomy Patients — OTHER · NA
• Prevention of Radiation-induced Severe Oral Mucositis in Oral Cavity, Oropharynx, Hypopharynx, and Cavum Cancer — TERMINATED · PHASE3
• Accelerated Radiotherapy and Concomitant Chemo-radiotherapy in HNSCC — COMPLETED · PHASE3
• Radiotherapy With Cisplatin Versus Radiotherapy With Cetuximab After Induction Chemotherapy for Larynx Preservation — COMPLETED · PHASE2
• Motexafin Gadolinium With Chemotherapy and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer — TERMINATED · PHASE1
• Very Intense Radiotherapy-Chemotherapy Regimen in Advanced HNSCC — COMPLETED · PHASE2

Refine this search